SCHEMBL4963192

SCHEMBL4963192

[O-][n+]1nccnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11262274 0.59
SCHEMBL1845346 0.55
SCHEMBL30977053 0.55
SCHEMBL28462068 0.44
Charcoal, Activated SCHEMBL30186803 0.44
SCHEMBL32662715 0.44
SCHEMBL51586 0.44
Hydrochloric Acid SCHEMBL8841269 0.42
Hydrochloric Acid SCHEMBL2411891 0.42
SCHEMBL17476670 0.42

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104447762-A Energetic ionic salts of 7-nitryl-4-ketone-4,8-dihydro-[1,2,4] triazole [5,1-d] [1,2,3,5] tetrazine-2-oxide and preparation method of energetic ionic salt BEIJING INST TECHNOLOGY 2015-03-25 CN claimed
CN-104447762-A Energetic ionic salts of 7-nitryl-4-ketone-4,8-dihydro-[1,2,4] triazole [5,1-d] [1,2,3,5] tetrazine-2-oxide and preparation method of energetic ionic salt BEIJING INST TECHNOLOGY 2015-03-25 CN disclosed
CN-104447762-A Energetic ionic salts of 7-nitryl-4-ketone-4,8-dihydro-[1,2,4] triazole [5,1-d] [1,2,3,5] tetrazine-2-oxide and preparation method of energetic ionic salt BEIJING INST TECHNOLOGY 2015-03-25 CN disclosed
CN-104447762-A Energetic ionic salts of 7-nitryl-4-ketone-4,8-dihydro-[1,2,4] triazole [5,1-d] [1,2,3,5] tetrazine-2-oxide and preparation method of energetic ionic salt BEIJING INST TECHNOLOGY 2015-03-25 CN disclosed
EP-1896505-A2 ANTI-IGF1R ANTIBODY FORMULATIONS SCHERING CORPORATION (US) 2008-03-12 EP disclosed
WO-2006138315-A2 ANTI-IGF1R ANTIBODY FORMULATIONS SCHERING CORPORATION (US) 2006-12-28 WO disclosed